Distribution of trans-resveratrol and its metabolites after acute or sustained administration in mouse heart, brain, and liver. (Q48324778)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

title

Distribution of trans-resveratrol and its metabolites after acute or sustained administration in mouse heart, brain, and liver (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

author

Valérie Nivet-Antoine

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Charles-Henry Cottart

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

author name string

Marie-Claude Menet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Stephanie Baron

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Meryam Taghi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Remi Diestra

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Delphine Dargère

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Olivier Laprévote

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Jean-Louis Beaudeux

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Tatiana Bédarida

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

publication date

21 March 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

Molecular Nutrition and Food Research

1 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

The journey of resveratrol from yeast to human

1 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Resveratrol supplementation: Where are we now and where should we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Neuroprotective properties of resveratrol and derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Resveratrol in cardiovascular health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Anti-diabetic effects of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Metabolism and bioavailability of trans-resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Bioavailability of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Sulfated and Glucuronated trans-Resveratrol Metabolites Regulate Chemokines and Sirtuin-1 Expression in U-937 Macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Influence of glucuronidation and reduction modifications of resveratrol on its biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Resveratrol bioavailability and toxicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Ultra high performance liquid chromatography-quadrupole-time of flight analysis for the identification and the determination of resveratrol and its metabolites in mouse plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Resveratrol metabolism in a non-human primate, the grey mouse lemur (Microcebus murinus), using ultra-high-performance liquid chromatography-quadrupole time of flight

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailability and tissue distribution of trans-resveratrol in knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Resveratrol: a supplementation for men or for mice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Dual effects of resveratrol on arterial damage induced by insulin resistance in aged mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Inhibition of cancer growth by resveratrol is related to its low bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Validated LC-MS/MS method for simultaneous quantification of resveratrol levels in mouse plasma and brain and its application to pharmacokinetic and brain distribution studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Bioavailability of trans-resveratrol from red wine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Absorption of three wine-related polyphenols in three different matrices by healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Resveratrol induces a mitochondrial complex I-dependent increase in NADH oxidation responsible for sirtuin activation in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Resveratrol Directly Binds to Mitochondrial Complex I and Increases Oxidative Stress in Brain Mitochondria of Aged Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Resveratrol and its metabolites inhibit pro-inflammatory effects of lipopolysaccharides in U-937 macrophages in plasma-representative concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Impact of trans-resveratrol-sulfates and -glucuronides on endothelial nitric oxide synthase activity, nitric oxide release and intracellular reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Resveratrol supplementation confers neuroprotection in cortical brain tissue of nonhuman primates fed a high-fat/sucrose diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Pharmacokinetic Study oftrans-Resveratrol in Adult Pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

Metabolites and tissue distribution of resveratrol in the pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600686

21 January 2018

Identifiers

DOI

10.1002/MNFR.201600686

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28160405%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

1 reference